News

FDA Recalls Contaminated Insulin Syringes


 

The Food and Drug Administration has announced the recall of Closercare insulin syringes and the extension of an earlier recall of Ultilet insulin syringes due to bacterial contamination with Paenibacillus.

The recall includes Closercare insulin syringe 29g 1cc with lot number 5JCZ1 as displayed on the inner case.

The recall also includes Ultilet insulin syringe 30g 1/2 cc with product lot number 5KEO1.

Patients with products from these lots should stop use and return the syringes to the manufacturer.

This bacterial contamination presents a risk of local infection, as well as a risk of the introduction of contaminating organisms into a previously sterile vial.

Moreover, the introduced contamination may degrade the insulin, which could lead to problems maintaining insulin levels.

For more information, contact Boca Medical Products Inc. by calling 800–354–8460.

Recommended Reading

Clinical Capsules
MDedge Family Medicine
Diabetic Neuropathic Pain Requires Perseverance
MDedge Family Medicine
Guidelines Advise Monitoring Diabetics for Chronic Kidney Disease
MDedge Family Medicine
Don't Immediately Switch Bone Agents if BMD Fails to Improve
MDedge Family Medicine
Three-Year Diabetes Initiative Aims to Improve Quality of Care
MDedge Family Medicine
Tool Screens for Latent Autoimmune Diabetes
MDedge Family Medicine
Clanging Tuning-Fork Test Zeros In on Nondiabetic Neuropathy
MDedge Family Medicine
Type 2 Diabetes' Effects on Pregnancy Underestimated
MDedge Family Medicine
Gender Disparities Dog Type 2 Care; Women's CVD Risks Undertreated
MDedge Family Medicine
PM Hypertension Flags Type 1 Complications
MDedge Family Medicine